Prevalence and Patterns of Multimorbidity among Human Immunodeficiency Virus Positive People in Odisha, India: An Exploratory Study
Introduction: Improved and efficient Anti-Retroviral Therapy (ART) has turned HIV positive into a chronic disorder. The increase in life expectancy and quality of life comes with an increased risk of multimorbidity from the traditional risk factors. Aim: To explore the prevalence of multimorbid...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2017-06-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/10014/22766_CE[Ra1]_F(RK)_PF1(SwG_SS)_PFA(SS)_PF2(P_VTNE).pdf |
| Summary: | Introduction: Improved and efficient Anti-Retroviral Therapy
(ART) has turned HIV positive into a chronic disorder. The
increase in life expectancy and quality of life comes with
an increased risk of multimorbidity from the traditional risk
factors.
Aim: To explore the prevalence of multimorbidity among People
Living with HIV (PLHIV).
Materials and Methods: An exploratory cross-sectional study
was carried out in an ART center of Odisha, India, from November
2013 to December 2013. A systematic random sampling was
done to include 197 adult HIV positive patients receiving ART
at least for one year or more. A structured questionnaire was
used to collect data on socio-demographic profile, ART status,
multimorbidity and opportunistic infections.
Results: The prevalence of multimorbidity was 47.7% (95% CI
41% to 55%). Among them, the most common chronic conditions
were pulmonary tuberculosis (28.4%), gastro-intestinal conditions
(7.1%), neural disorders (5.1%) and hypertension (2.5%). In total,
48.7% had opportunistic infections; with 36% bacterial, 25%
fungal and 21% viral infections.
Conclusion: The prevalence of multimorbidity was high among
HIV positive patients. Further research should explore the
epidemiology of multimorbidity among HIV positive patients to
formulate proper clinical practice guidelines to enhance longterm outcomes of PLHIV in the current treatment era. |
|---|---|
| ISSN: | 2249-782X 0973-709X |